Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemiaMonika Podhorecka, Zbigniew Darżynkiewicz, Arkadiusz Macheta et al.|Oncotarget|2016Cited by 59
Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patientsNorbert Grząśko, Anna Dmoszyńska, Adam Walter‐Croneck et al.|Hematological Oncology|2012Cited by 48
The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple MyelomaSzymon Zmorzyński, Agata Filip, Iwona Korszeń-Pilecka et al.|Frontiers in Oncology|2019Cited by 38
ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple MyelomaSzymon Zmorzyński, Agata Filip, Iwona Korszeń-Pilecka et al.|Frontiers in Oncology|2019Cited by 36
Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells numberMonika Podhorecka, Marek Hus, Agnieszka Szymczyk et al.|Oncotarget|2017Cited by 34